Results 241 to 250 of about 38,429 (312)
Sclerosing diseases of the skin
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Yasamin Kalantari +4 more
wiley +1 more source
In this prospective sub‐study testing the predictive validity of General Movements Assessment (GMA) and/or Hammersmith Infant Neurological Examination (HINE), 785 infants with birth/infant‐detectable risk factors, aged 12 to 40 weeks corrected age were recruited. GMA and HINE were reliable and accurate tools for screening high‐risk populations in India,
Katherine A. Benfer +13 more
wiley +1 more source
Correction to Supporting Information for Li et al., Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia. [PDF]
europepmc +1 more source
Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial. [PDF]
Toth GG +14 more
europepmc +1 more source
Modeling cerebral palsy in animals
Abstract Advancements in the treatment of cerebral palsy depend on animal research. Yet, most animal models have not been fully evaluated for spasticity and dystonia using clinically relevant measures of altered tone or movement patterns, which form the basis for diagnosing people with the condition.
Katharina A. Quinlan +8 more
wiley +1 more source
2. Angiogenic Therapy for Critical Limb Ischemia
Yusuke Nakagawa +4 more
openalex +2 more sources
Abstract Objective Patients with newly diagnosed epilepsy exhibit brain white matter (WM) abnormalities, but the temporal dynamics of these are unknown. The literature suggests these alterations might be present before diagnosis. This study investigates WM microstructural integrity using diffusion imaging in non‐lesional (NL), interictal epileptiform ...
Marysol Segovia‐Oropeza +3 more
wiley +1 more source
Abstract Objective Developmental and epileptic encephalopathy type 1 (DEE1) is a rare drug‐resistant pediatric epilepsy caused by trinucleotide repeat expansions in the X‐linked ARX gene, leading to elongation of the first polyalanine tract. It presents with early onset tonic seizures or spasms, developmental and cognition delay, and high risk of ...
Lucia Verrillo +9 more
wiley +1 more source
[The application of cell products for the treatment of critical limb ischemia in patients with diabetes mellitus: a review of the literature]. [PDF]
Chugan GS +3 more
europepmc +1 more source
Abstract Epilepsy affects approximately 1% of the population worldwide, and although medications are effective in the majority of cases, seizures persist in approximately 30% of patients. Despite the effort to develop new antiseizure drugs, the rate of pharmacoresistance in patients has not diminished over the past 3 decades. There is thus a real unmet
Vincent Magloire +9 more
wiley +1 more source

